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Abstract 
Insulin-like growth factors (IGF) modulate placental and fetal growth and development 
through nutrient sensing and endocrine signaling. We hypothesized that poor maternal nutrition 
during gestation would alter IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 mRNA 
expression in the ovine placenta, but would not affect IGF-II mRNA expression. Pregnant ewes 
(n=57) were individually fed: 60% (restricted fed; RES), 100% (control fed; CON), or 140% 
(over fed; OVER) of National Research Council requirements for TDN starting at day 30±0.2 of 
gestation. Ewes were euthanized and cotyledon and caruncle samples were collected at days 45, 
90, and 135 of gestation. Relative mRNA expression of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 
was quantified using real-time PCR. Data were analyzed using the MIXED procedure in SAS. 
Relative IGF-I mRNA expression was less at day 45 than at days 90 and 135 in the caruncle (P < 
0.001; d45: 0.96 ± 0.06, d90: 1.28 ± 0.06, d135: 1.38 ± 0.05). In the caruncle, IGFBP-2 
expression was less at day 45 than at days 90 and 135 (P < 0.001; d45: 0.67 ± 0.20, d90: 1.90 ± 
0.20, d135: 1.65 ± 0.18).  There was no detectable impact of diet or time on IGF-II or IGFBP-3 
expression in the caruncle (P > 0.12). In the cotyledon, IGF-I expression tended to be greater in 
RES than OVER, which was similar to CON (P = 0.08; RES: 1.10 ± 0.06, OVER: 0.89 ± 0.07, 
CON: 0.96 ± 0.07).  Relative IGF-II mRNA expression was greater in RES than OVER 
cotyledons (P = 0.01; RES: 1.96 ± 0.31, OVER: 0.54 ± 0.32, CON: 1.30 ± 0.35). Relative 
IGFBP-2 mRNA expression decreased over time in the cotyledon (P < 0.001; d45: 1.26 ± 0.12, 
d90: 0.93 ± 0.12, d135: 0.59 ± 0.11).  Relative IGFBP-3 mRNA expression was less in RES than 
in OVER or CON cotyledons (P = 0.009; RES: 0.03 ± 0.57, OVER: 3.62 ± 0.66, CON: 1.84 ± 
0.64). In response to poor maternal diet, changes in IGF expression in the cotyledon were greater 
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than in the caruncle, suggesting a potential mechanism by which maternal-fetal exchange may be 
modified to restrict placental and fetal growth. 
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Review of Literature 
Introduction 
 Fetal development is a tightly regulated period of rapid growth. Therefore, modulations 
to the intrauterine environment throughout gestation can negatively impact normal patterns of 
fetal growth and development in offspring with persistent effects in the early postnatal period 
through to maturity. Maternal nutrition, defined as the diet the mother consumes before breeding, 
throughout gestation, and during lactation (American Journal of Public Health, 1973) has the 
potential to influence the intrauterine environment by modulating the availability of nutrients, 
growth factors, and hormones to the developing fetus (McMullen et al., 2005). Poor maternal 
nutrition during gestation due to either overnutrition or undernutrition can have detrimental 
anatomical and physiological effects on the offspring including decreased placental 
vascularization, decreased birth weight, decreased muscle development, and increased fat 
deposition (Redmer et al., 2004; Hoffman et al., 2014; Reed et al., 2014). These effects alter 
postnatal growth of the offspring, indicating the importance of maternal nutrition during 
gestation on offspring development. 
 
Normal Placental Development 
Ruminants have a cotyledonary placenta, which consists of a maternal contribution, the 
caruncle, and a fetal contribution, the cotyledon. The caruncle and the cotyledon interdigitate at 
discrete sites in the placenta called placentomes. Materno-fetal exchange of nutrients, gases, and 
waste products occurs at the placentomes. As described by Reynolds et al. (1997), the fetal 
membranes attach to the endometrial epithelium of the uterus on days 15 to 18 of gestation with 
the interdigitation of the caruncle and the cotyledon beginning on day 23 of gestation. By day 30 
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of gestation, the placentomes are well established and interdigitation is complete. The individual 
placentomes and the placenta itself continue to grow in size until day 90 of gestation, when the 
placenta achieves its maximum weight in sheep (Redmer et al., 2004). In sheep, the majority of 
placental growth occurs in the first two-thirds of pregnancy, while approximately 90% of fetal 
growth occurs in the last third of pregnancy (day 90 to day 145; Redmer et al., 2004). 
Insulin-like growth factors (IGF) are nutritionally sensitive endocrine factors that regulate 
fetal and placental growth and development. The IGFs regulate processes involved in 
development by promoting cellular proliferation, differentiation, migration and aggregation, and 
inhibiting apoptosis (Jones & Clemmons, 1995; Carter et al., 2005). IGF-I and IGF-II have 
complimentary yet overlapping roles in optimizing nutrient partitioning to the fetus to optimize 
growth and development. IGF-I regulates fetal growth by partitioning nutrients to the fetus in 
response to nutrient availability (Sferruzzi-Perri et al., 2010). IGF-II acts directly on the placenta 
to modulate the thickness and surface area of the materno-fetal interface (Sibley et al., 2004; 
Sferruzzi-Perri et al., 2010). IGF-II is more abundant in maternal plasma than IGF-I irrespective 
of reproductive state in many species, including sheep (Sferruzzi-Perri et al., 2010; Kadakia & 
Josefson, 2016). 
The bioavailability and biological actions of IGFs are regulated by IGF binding proteins 
(IGFBP). All six of these binding proteins specifically bind to IGF-I and IGF-II; however, they 
do so with differing affinities. While IGFBP-1, -3, and -4 bind IGF-I and IGF-II with similar 
affinities, IGFBP-2, -5, and -6 preferentially bind to IGF-II (Rajaram et al., 1997; Reynolds et 
al., 1997). It is well documented that IGFBPs function to limit the bioavailability of IGFs in 
circulation; however, this family of six high-affinity binding proteins either inhibits or 
potentiates the actions of IGFs on metabolism and mitogenesis based on the tissue and the post-
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translational modifications of individual IGFBPs (Rajaram et al., 1997; Reynolds et al., 1997; 
Carter et al., 2005; Denley et al., 2005). The specific actions of the IGFBPs in placental tissue 
are not yet fully understood. The IGFBPs are not only capable of modulating IGF-induced cell 
proliferation but most of the IGFBPs have also been shown to act in IGF-independent pathways 
(Rajaram et al., 1997; Denley et al., 2005; McMullen et al., 2005). Due to the complexity of the 
IGFBP functions and the lack of understanding of the pathways with which they exert their IGF-
independent effects, it is clear that the significance of changes in concentrations of the six IGFBP 
in placental tissue requires further study. 
 
Potential Mechanisms for Altered Placental Development 
Poor maternal nutrition during gestation has been associated with a decrease in birth 
weight of offspring and a decrease in placental weight (Gadd et al., 2000; Osgerby et al. 2004; 
McMullen et al., 2005). Both high and low planes of maternal nutrition throughout gestation 
have similar negative effects on the growth of the fetus (Gadd et al., 2000; Hoffman et al., 2014). 
IGF-I concentration in plasma increases over the course of gestation (Carter et al., 2005). Plasma 
IGF-I concentrations correlate with nutritional status, as IGF-I decreases in under-fed ewes 
compared with control-fed ewes and increases in over-fed compared with control-fed ewes 
(Gallaher et al., 1998; Gadd et al., 2000; McMullen et al., 2005). Relative mRNA expression of 
IGF-I in placental tissue is not well described as IGF-I mRNA concentrations fall below the limit 
of detection for in-situ hybridization assays in maternal nutrient restriction experiments shortly 
after the invasion of the fetal villi (Reynolds et al., 1997; McMullen et al., 2005). While IGF-I 
expression is both nutritionally and time-point sensitive in maternal plasma and serum, IGF-II 
mRNA expression remains constant throughout gestation and is nutritionally independent in 
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maternal plasma, maternal serum, and placental samples (Gadd et al., 2000; Osgerby et al., 2004; 
McMullen et al., 2005). 
Previous studies have presented conflicting results regarding the placental expression of 
IGFBP-2 mRNA in ewes exposed to poor maternal nutrition.  McMullen et al. (2005) and Gadd 
et al. (2000) report that the concentrations of IGFBP-2 mRNA are reduced in nutrient restricted 
ewes during early gestation and increased in ewes exposed to high plane rations in mid-gestation, 
respectively.  However, Osgerby et al. (2004) reported that mRNA expression of IGFBP-2 
throughout gestation was nutritionally and time-point independent. While the effects of IGFBP-2 
in the placenta are not well understood, IGFBP-2 has been shown to be mitogenic in IGF-
independent pathways in human uterine endometrial epithelial cells and osteosarcoma cells 
(Firth & Baxter, 2002).  
IGFBP-3, the most abundant binding protein in placental tissue in women, exhibits both 
nutritionally and time-point sensitive mRNA expression (Forbes & Westwood, 2008). 
Concentrations of IGFBP-3 mRNA were reduced in the caruncles at day 90 in maternal 
undernutrition experiments (Osgerby et al., 2004; McMullen et al., 2005). Relative mRNA 
expression of IGFBP-3 was increased in fetal placental tissue of over-fed ewes compared with 
control-fed ewes (Gadd et al., 2000). The direct effects of IGFBP-3 on placental tissue is not 
well understood; however, IGFBP-3 has been reported to have IGF-independent growth 
inhibitory effects in IGF Receptor 1-knockout mice (Firth & Baxter, 2002). In opossum kidney 
cells, intact IGFBP-3 inhibited cell growth due to direct nuclear actions (Rechler & Clemmons, 
1998). Several studies have found evidence that intact IGFBP-3 has a mediating role in a wide 
range of growth effectors, such as TGFβ, retinoic acid, antiestrogens, vitamin D analogs, and 
TNFα (Firth & Baxter, 2002). Fragments and proteolyzed forms of IGFBP-3, which have little to 
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no affinity for IGFs, have also been shown to inhibit mitogenesis in the fibroblasts of chick 
embryos and mice via IGF-independent pathways (Firth & Baxter, 2002). 
 
Objectives and Hypothesis 
The placenta is an important determinant of fetal growth rate. Therefore, relative 
expression of IGFs and IGFBPs in the placenta can be used as an indicator of the effect of 
environmental stressors on the growth and development of the fetus throughout gestation. The 
objective of this study is to determine alterations in transcription of IGF-I, IGF-II, IGFBP-2, and 
IGFBP-3 by poor maternal nutrition throughout gestation. This study is the first comprehensive 
study to describe the effects of both undernutrition and overnutrition on the relative mRNA 
expression of IGFs and IGFBPs over the course of gestation. Given the great implications of 
maternal stressors, including poor maternal nutrition during gestation, on postnatal growth and 
overall health of the animal, it is important to understand the effects of maternal stressors on fetal 
development. Examining the effects of both underfeeding and overfeeding ewes throughout 
gestation provides further insight into optimal nutrient requirements for lamb production as well 
as the duration a fetus can be exposed to poor maternal nutrition before the onset of the 
detrimental effects associated with poor maternal nutrition. Based on results of related studies, 
we hypothesized that poor maternal nutrition during gestation would cause a change in the 
mRNA expression of IGF-I, IGFBP-2, and IGFBP-3 in the ovine placenta, but would not affect 
the mRNA expression of IGF-II. 
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Materials and Methods 
Animals and Sample Collection 
All animal procedures were reviewed and approved by the University of Connecticut’s 
Institutional Animal Care and Use Committee (protocol number: A13-059).  
Animal procedures were previously reported in Pillai et al. (2017). For this project, 
multiparous Western White-Faced ewes (n= 57) were randomly assigned one of three diets: 
restricted (RES; 60%), control (CON, 100%), or over-fed (OVER; 140%) based on National 
Research Council requirements for total digestible nutrients starting at d30 ± 0.2 of gestation 
(Figure 1). Ewes were euthanized via intravenous injection of Beuthanasia-D Special (0.22 
mL/kg; Merck Animal Health; Summit, NJ) at days 45, 90, and 135 of gestation. Placental 
samples from the cotyledon and caruncle (n= 4 to 7 ewes per treatment per time point) were 
collected during necropsy, immediately snap frozen in liquid nitrogen, and stored at -80°C. 
While fetal tissues were also collected at parturition, placental tissue was not recovered. 
 
RNA Extraction 
 Tissue was homogenized using a Qiagen TissueLyser Bead Homogenizer (Qiagen, 
Valencia, CA). Total RNA was extracted using a standard phenol-chloroform extraction. The 
quantity of RNA was determined using a Nanodrop spectrophotometer (Thermoscientific, 
Lafayette, CO).  
 
Real-Time Quantitative Polymerase Chain Reaction 
 Isolated RNA was reverse transcribed to complimentary DNA using a SuperScript III kit 
(Invitrogen, Carlsbad, CA) according to manufacturer’s protocol. Briefly, 1 L OligodT primer 
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(Invitrogen), 1,000 ng total RNA, 1 L dNTP mix (Invitrogen), and sterile water were mixed to a 
total reaction volume of 10 L. The mixture was heated to 65C for 5 minutes and incubated on 
ice for 1 minute. A cDNA master mixture composed of 4 L of 5x First-Strand Buffer 
(Invitrogen), 1 L DDT (Invitrogen), 1 L RNase Out (Invitrogen), 1 L SuperScript III 
(Invitrogen), and 5 L RNase Free water (Invitrogen), was then added to the reaction. Reverse 
transcription was performed with a standard protocol starting at 25C for 5 minutes, 50C for 60 
minutes, and 70C for 15 minutes. Complimentary RNA was removed by adding 2 units of 
Escherichia coli RNase H to the reaction and incubating the mixture at 37C for 60 minutes. 
Primers were designed for genes involved in the somatotropic axis (IGF-I, IGF-II, IGFBP-2, and 
IGFBP-3; Table 1) using NCBI BLAST and synthesized by Integrated DNA Technologies 
(Coralsville, IA). All primers with the exception of IGF-II were validated by Hoffman et al. 
(2014). The IGF-II primer was validated by Xing et al. (2014). Real-time quantitative 
polymerase chain reaction (RT-qPCR) was performed using SYBR Green Master Mix 
(Invitrogen) and the ABI 7900 HT Fast Real-time PCR machine (Applied Biosystems, Foster 
City, CA) according to the manufacturer’s protocol. The total volume of the reaction mixture 
was 25 L containing 12.5 L SYBR Green Master Mix (Invitrogen), 0.225 L each of 10 nM 
forward and reverse primer (Integrated DNA Technologies), 7.05 L of nuclease free water, and 
5 L generated cDNA. Real-time qPCR was performed using standard cycling conditions (stage 
1: 50C for 2 minutes, stage 2: 95C for 10 minutes, stage 3: 95C for 15 seconds and 60C for 1 
minute for 40 cycles). Ct values were utilized to calculate the Ct values to determine changes 
in gene expression. Gene expression was normalized to glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), as its expression did not vary between treatments or time points. Gene 
expression was expressed as fold change relative to controls at day 45. 
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Statistical Analysis 
 Data were analyzed using the PROC MIXED procedure (SAS Institute, Inc., Cary, NC) 
with main effects of diet, time point, and the interaction of diet and timepoint. The PDIFF 
statement was utilized to determine differences between means. Data are reported as mean ± 
SEM, with P < 0.05 considered significant and 0.05 < P < 0.10 considered a tendency.  
 
Results 
Day of gestation altered IGF-I and IGFBP-2 mRNA expression in the caruncle.  
In the caruncle, relative IGF-I mRNA expression was less at day 45 than at days 90 and 
135 of gestation (P < 0.001; d45: 0.96 ± 0.06, d90: 1.28 ± 0.06, d135: 1.38 ± 0.05; Figure 2). 
Relative mRNA expression of IGFBP-2 was less at day 45 than at days 90 and 135 of gestation 
(P < 0.001; d45: 0.67 ± 0.20, d90: 1.90 ± 0.20, d135: 1.65 ± 0.18; Figure 2). There was no 
detectable impact of time on relative mRNA expression of IGF-II or IGFBP-3 in the caruncle (P 
> 0.05; Figure 2). Dietary treatment did not significantly alter relative mRNA expression of IGF-
I, IGF-II, IGFBP-2, or IGFBP-3 in the caruncle (P > 0.05). 
 
Maternal diet altered IGF-II and IGFBP-3 mRNA expression in the cotyledon.  
In the cotyledon, expression of IGF-I tended to be greater in RES than OVER with CON 
intermediate (main effect of diet: P = 0.08; RES: 1.10 ± 0.06, OVER: 0.89 ± 0.07, CON: 0.96 ± 
0.07; Figure 3). Relative IGF-II mRNA expression was greater in RES than OVER cotyledons 
with CON intermediate (main effect of diet: P = 0.01; RES: 1.96 ± 0.31, OVER: 0.54 ± 0.32, 
CON: 1.30 ± 0.35; Figure 3). Relative IGFBP-3 mRNA expression was less in RES than in 
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OVER or CON cotyledons (main effect of diet: P = 0.009; RES: 0.03 ± 0.57, OVER: 3.62 ± 
0.66, CON: 1.84 ± 0.64; Figure 3). Maternal diet had no detectable effect on relative mRNA 
expression of IGFBP-2 in the cotyledon (P > 0.05; Figure 3). 
 
Day of gestation altered IGFBP-2 mRNA expression in the cotyledon.  
Relative IGFBP-2 mRNA expression decreased over time in the cotyledon (P < 0.001; 
d45: 1.26 ± 0.12, d90: 0.93 ± 0.12, d135: 0.59 ± 0.11; Figure 4). There were no significant 
detectable effects of time on relative mRNA expression of IGF-I, IGF-II, or IGFBP-3 in the 
cotyledon (P > 0.05; Figure 4).  
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Table 1. Primer sequences for real-time qPCR. 
 
Gene Primer Sequences References 
IGF-I 
     Forward 
     Reverse 
 
5’-CCAGACAGGAATCGTGGATG-3’ 
5’- ACTTGGCGGGCTTGAGAG-3’ 
Hoffman et al., 2014 
IGF-II 
     Forward 
     Reverse 
 
5’-TTCTTCCAATCTGACACCTG-3’ 
5’-AGGCAGGGCGATCAGCGGACGGTGA-3’ 
 
Xing et al., 2014 
IGFBP-2 
     Forward 
     Reverse 
 
5’- CCCTACACATCCCCAACTGT-3’ 
5’- CAGTGTTGGGGTTCACACAC-3’ 
 
Hoffman et al., 2014 
 
IGFBP-3 
     Forward 
     Reverse 
 
5’- CAGAGCACAGACACCCAGAA-3’ 
5’- CACAGTTGGGAATGTGGATG-3’ 
 
 
Hoffman et al., 2014 
GAPDH 
     Forward 
     Reverse 
 
5’-GGCGTGAACCACGAGAAGTATAA-3’ 
5’- CCTCCACGATGCCAAAGTG-3’ 
Hoffman et al., 2014 
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Figure 1. Experimental Design. Experimental design, adapted from Pillai et al. (2017). 
Pregnant ewes (n = 57) were randomly assigned to one of three dietary treatments beginning at d 
30 ± 0.2 of gestation (CON = 100% NRC; RES = 60% NRC; OVER = 140% NRC). At day 45, 
90, or 135 of gestation, ewes were euthanized and placental samples were collected during 
necropsy. The placental samples were dissected into two distinct tissues: the caruncle (car) and 
cotyledon (cot). The samples were placed into individual tubes, snap frozen in liquid nitrogen, 
and stored at -80°C (n = 4 to 7 ewes per treatment combination per tissue). 
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Figure 2. Day of gestation altered IGF-I and IGFBP-2 mRNA expression in the caruncle. 
Gene expression of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (BP)-2, and 
IGFBP-3 was analyzed in the caruncle. Relative mRNA expression of IGF-I and IGFBP-2 were 
less at day 45 than at days 90 and 135 (P < 0.001 for both genes). Data are expressed as mean ± 
SEM. Within each gene, means with different letters are different at P < 0.05. 
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Figure 3. Maternal diet altered IGF-II and IGFBP-3 mRNA expression in the cotyledon. 
Gene expression of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (BP)-2, and 
IGFBP-3 was analyzed in the cotyledon. Relative IGF-II mRNA expression was greater in RES 
than OVER cotyledons (main effect of diet: P = 0.01). Relative IGFBP-3 mRNA expression was 
less in RES than in OVER or CON cotyledons (main effect of diet: P = 0.009). Data are 
expressed as mean ± SEM. Within each gene, means with different letters are different at P < 
0.05. 
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Figure 4. Day of gestation alters IGFBP-2 mRNA expression in the cotyledon. Gene 
expression of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (BP)-2, and IGFBP-
3 was analyzed in the cotyledon. Relative IGFBP-2 mRNA expression decreased over time (P < 
0.001). Data are expressed as mean ± SEM. Within each gene, means with different letters are 
different at P < 0.05. 
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Discussion 
Previous studies investigating the effects of poor maternal nutrition during gestation on 
placental expression of IGFs and IGFBPs have focused on either restricted- (Gallaher et al., 
1998; Osgerby et al., 2004; McMullen et al., 2005) or over-feeding (Gadd et al., 2000). 
Additionally, the models utilized in previous experiments studied only the acute effects of poor 
maternal nutrition (Gallaher et al., 1998; Osgerby et al., 2004; McMullen et al., 2005). The aim 
of this study was to determine the effects of both over- and under-feeding throughout gestation 
on placental mRNA expression of IGF-I, IGF-II, IGFBP-2, and IGFBP-3 in both the caruncle 
and the cotyledon. The caruncle and cotyledon were analyzed separately to identify potential 
mechanisms through which changes in expression of the IGFs and IGFBPs induced by poor 
maternal nutrition in either of these tissues may contribute to the restricted placental and fetal 
growth observed in previous studies (Gadd et al., 2000; Osgerby et al., 2004; Redmer et al., 
2004; Carter et al., 2005; Pillai et al., 2017). We found that maternal diet altered the expression 
of IGF-II and IGFBP-3 in the cotyledon, but did not alter expression of any of the IGFs or 
IGFBPs studied in the caruncle. 
 
Maternal diet altered IGF-II and IGFBP-3 mRNA expression in the cotyledon.  
 In this study, relative IGFBP-3 mRNA expression was less in RES than in OVER or 
CON cotyledons. This result is consistent with the observations of Gallaher et al. (1998) in 
which IGFBP-3 concentrations were decreased in fetal plasma in under-fed ewes. This result is 
also consistent with an observed reduction of plasma IGFBP-3 in underfed guinea pigs (Carter et 
al., 2005). IGFBP-3 has an equal binding affinity for IGF-I and IGF-II and binds 95% of 
circulating IGF-I and IGF-II (Reynolds et al., 1997). The decrease in placental expression of 
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IGFBP-3 in restricted-fed ewes concurrent with the increase in IGF-II would allow for an 
increase in the bioavailability of IGF-II. The increase in bioavailable IGF-II would then allow for 
an increase in placental surface area and decrease in placental thickness, similar to those effects 
observed in guinea pigs (Roberts et al., 2008; Forbes & Westwood, 2008; Forbes & Westwood, 
2010; Sferruzzi-Perri et al., 2010). Roberts et al. (2008) reported that plasma IGF-II 
concentrations correlate positively with placental surface area and negatively with placental 
thickness in guinea pigs. When interpreted in this context, the increase in IGF-II expression in 
RES cotyledons compared with OVER cotyledons is intuitive physiologically. A restricted-fed 
ewe has less nutrients available for the fetus and the ewe will partition nutrients to the fetus at the 
expense of her own requirements. The increase in placental expression of IGF-II would cause a 
concurrent increase in placental surface area and decrease in the thickness of the placenta, 
allowing for the passage of nutrients from maternal to fetal circulation to occur at a more rapid 
rate. Similarly, the decrease in IGF-II expression in the OVER cotyledons would decrease 
placental surface area while increasing barrier thickness. The decrease in the rate of passage of 
nutrients from maternal to fetal circulation due to these physiological changes to the placenta 
would protect the fetus from over-exposure to nutrients, allowing for a more optimal intrauterine 
environment for growth. IGFBP-2 expression was not impacted by maternal diet in this study, 
potentially allowing an increase in bioavailability of IGF-II which may result in the above 
described physiological changes in the placenta. However, the nutritional dependence of IGF-II 
expression in the cotyledons is contradictory to in-situ hybridization studies that indicate that 
placental expression of IGF-II is nutritionally independent (Gadd et al., 2000; Osgerby et al., 
2004; & McMullen et al., 2005). This discrepancy in results could be due to the different 
methods utilized in the experiments. The in-situ hybridization studies utilized an image analysis 
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system and quantified the results using optical density units. In this study, however, we utilized 
real-time qPCR which is more sensitive and accurate in quantifying the concentrations of 
compounds such as IGFs and IGFBPs (Biedermann et al., 2004; Thermo Fisher Scientific Inc., 
2020). 
 IGFBP-3 has an equal binding affinity for IGF-I and IGF-II and binds 95% of circulating 
IGF-I and IGF-II (Reynolds et al., 1997). In this study, relative IGFBP-3 mRNA expression was 
less in RES than in OVER or CON cotyledons. This result is consistent with the observations of 
Gallaher et al. (1998) in which IGFBP-3 concentrations were decreased in fetal plasma in under-
fed ewes and with an observed reduction of plasma IGFBP-3 in underfed guinea pigs (Carter et 
al., 2005). The decrease in placental expression of IGFBP-3 in restricted-fed ewes concurrent 
with the increase in IGF-II would allow for an increase in the bioavailability of IGF-II. The 
increase in bioavailable IGF-II would then allow for an increase in placental surface area and 
decrease in placental thickness, similar to those effects observed in guinea pigs, which would 
allow for the limited nutrients of the RES ewes to be more easily passed via the feto-maternal 
interface of the placentome to the fetus (Roberts et al., 2008; Sferruzzi-Perri et al., 2010). The 
nutrients would be partitioned to the fetus to allow for the fetus to grow at its maximum potential 
at the expense of the nutrient-restricted ewe. 
 
Day of gestation altered IGF-I in the caruncle and IGFBP-2 mRNA expression in both the 
caruncle and cotyledon. 
 Over the course of gestation, fetal demands for nutrients increase in preparation for the 
rapid period of fetal growth during late gestation (Redmer et al., 2004). Maternal IGF-I serum 
concentrations increase to accommodate the changes in nutrient demand, partitioning more 
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nutrients to the fetus to allow for optimal growth of the fetus at expense of the ewe. Previous 
studies indicate that maternal serum IGF-I concentrations increase over gestation (Carter et al., 
2005). Relative mRNA expression of IGF-I was less at day 45 than at days 90 and 135 in the 
caruncle. This change in mRNA expression was not observed in the cotyledon. The observed 
change in IGF-I expression in the maternal but not the fetal contribution to the placentome is 
consistent with the idea that IGF-I is essential in controlling nutrient partitioning (Sferruzzi-Perri 
et al., 2010).  The relative expression of IGFBP-2 in the caruncle mirrored the changes observed 
in IGF-I expression. While IGFBP-2 preferentially binds to IGF-II, it still has the capacity to 
bind to IGF-I and mitigate its bioavailability (Rajaram et al., 1997; Reynolds et al., 1997). The 
expression of IGF-II has been characterized as being time-point independent during gestation in 
sheep (Gadd et al., 2000; Osgerby et al., 2004; & McMullen et al., 2005). These results suggest 
that IGFBP-2 may be expressed in a similar pattern as IGF-I in the caruncle to maintain IGF-II 
concentrations throughout gestation while having a lesser effect on the bioavailability of IGF-I. 
The increase in IGFBP-2 decreases the bioavailability of IGF-II while having a more minimal 
impact on the bioavailability of IGF-I. This allows IGF-I concentrations to increase to meet the 
nutritional demands of the fetus throughout gestation while ensuring its concentrations remain 
within an appropriate physiological range. 
The majority of fetal growth occurs in the last third of pregnancy (day 90 to 145; Redmer 
et al., 2004). IGF-II regulates fetal growth by acting directly on the placenta to influence nutrient 
delivery to fetal cells (Sferruzzi-Perri et al., 2010). IGFBP-2 preferentially binds IGF-II, which 
plays an important role in regulating the surface area and thickness of the placenta as well as 
stimulating proliferation, differentiation, migration and aggregation of fetal cells (Jones & 
Clemmons, 1995; Sibley et al., 2004; Carter et al., 2005; Sferruzzi-Perri et al., 2010). Taken 
Caitlyn Splaine 
 22 
together, the decrease in fetal mRNA expression of IGFBP-2 throughout gestation in this study 
with its lowest relative expression during late gestation (day 135) could increase the 
bioavailability of fetal IGF-II, allowing for a greater influence of IGF-II on fetal growth and 
development during the period of rapid growth in late gestation. 
 
Conclusion 
In conclusion, poor maternal nutrition during gestation influenced the relative mRNA 
expression of IGF-I, IGF-II, and IGFBP-3 in the cotyledon, but had no effect on IGF-I, IGF-II, 
IGFBP-2, or IGFBP-3 expression in the caruncle or IGFBP-2 expression in the cotyledon. The 
IGF system was altered to a greater extent in the cotyledon than in the caruncle in response to 
poor maternal diet, suggesting a potential mechanism by which maternal-fetal exchange may be 
modified to restrict placental and fetal growth.  Relative mRNA expression of IGFs and IGFBPs 
in response to poor maternal nutrition warrants further study as there are few studies of this kind 
and the results of this study conflict with those found in experiments studying the effect of poor 
maternal nutrition on plasma concentration or in-situ hybridization of IGFs and IGFBPs. Future 
studies should also measure protein concentrations in placental tissue, fetal circulation, and 
maternal circulation to determine if the changes in transcription observed in this study are 
reflected in the protein concentrations. Further studies should investigate the effects both over- 
and under-feeding over the course of gestation on relative expression of IGF-I, IGF-II, and all six 
of the IGFBPs in both the cotyledon and the caruncle to allow for greater understanding of the 
interactions of the IGFs and IGFBPs in the placentome. Additional work should also focus on 
IGFBP-4, as it and its protease are associated with pregnancy and dysregulation of plasma 
IGFBP-4 in humans has been shown to contribute significantly to the development of fetal 
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growth restriction (Qiu et al., 2012). The results of this study indicate that the IGF system in the 
cotyledon was altered in reaction to poor maternal diet to maintain the bioavailable IGF-I and 
IGF-II concentrations in the placenta within appropriate physiological ranges to in an attempt to 
counteract fetal growth restriction caused by nutritional insult. Poor maternal nutrition has been 
correlated with restricted fetal and placental growth throughout gestation, resulting in a decrease 
in the productive part of the animal, the muscle. Therefore, it is important to understand the 
mechanisms and factors that contribute to restricted fetal growth caused by poor maternal 
nutrition. 
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